Pharmacological profiles of β-funaltrexamine (β-FNA) and β-chlornaltrexamine (β-CNA) on the mouse vas deferens preparation
- 1 June 1982
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 80 (4), 377-384
- https://doi.org/10.1016/0014-2999(82)90083-8
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Demonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexusNature, 1981
- The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexoneEuropean Journal of Pharmacology, 1981
- Morphine analgesia after intrathecal administration of a narcotic agonist, chloroxymorphamine and antagonist, chlornaltrexamineEuropean Journal of Pharmacology, 1980
- Selective development of tolerance without dependence in multiple opiate receptors of mouse vas deferensNature, 1980
- A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activitiesJournal of Medicinal Chemistry, 1980
- Synthesis and pharmacologic characterization of an alkylating analog chlornaltrexamine, of naltrexone with ultralong-lasting narcotic antagonist propertiesJournal of Medicinal Chemistry, 1979
- 6.beta.-[N,N-Bis(2-chloroethyl)amino]-17-(cyclopropylmethyl)-4,5.alpha.-epoxy-3,14-dihydroxymorphinan (chloranaltrexamine), a potent opioid receptor alkylating agent with ultralong narcotic antagonist activityJournal of Medicinal Chemistry, 1978
- Endogenous opioid peptides: multiple agonists and receptorsNature, 1977
- A New Concept on the Mode of Interaction of Narcotic Analgesics with ReceptorsJournal of Medicinal Chemistry, 1965
- SOME QUANTITATIVE USES OF DRUG ANTAGONISTSBritish Journal of Pharmacology and Chemotherapy, 1959